Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Sagimet Biosciences (SGMT) EPS (Weighted Average and Diluted) (2023 - 2024)

Sagimet Biosciences has reported EPS (Weighted Average and Diluted) over the past 2 years, most recently at -$0.5 for Q4 2024.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.5 for Q4 2024, down 189.29% from a year ago — trailing twelve months through Dec 2024 was -$1.43 (up 97.99% YoY), and the annual figure for FY2025 was -$1.58, down 8.97%.
  • EPS (Weighted Average and Diluted) for Q4 2024 was -$0.5 at Sagimet Biosciences, down from -$0.45 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for SGMT hit a ceiling of $0.56 in Q4 2023 and a floor of -$35.8 in Q2 2023.